Saturday, November 28, 2015         

 Print   Email   Most Popular   Save   Post   Retweet

Hawaii clinic in national drug study

By Star-Advertiser staff


The Retina Institute of Hawaii is participating in the national study of an investigational drug with potential for treating Wet Age-Related Macular Degeneration, which causes severe vision loss among the elderly.

Called AGN-150998, the Allergan company drug is designed to inhibit the growth of abnormal blood vessels, which may address retinal swelling problems.

Patients 50 and older will be randomly selected to participate in the study and will be followed for up to 32 weeks, at no cost to the patient.

 Print   Email   Most Popular   Save   Post   Retweet

Latest News/Updates